Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 23.89 billion as of July 10, 2026. Its market cap has increased by 34.31% in one year.

Market Cap

23.89B

Enterprise Value

24.12B

Revenue

3.85B

Ranking

n/a

PE Ratio

57.84

Stock Price

2,366.80

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 23.89B, an increase of 2,508.32%. That is a compound annual growth rate of 45.40%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2026	23.89B	52.79%
Dec 31, 2025	15.64B	-19.04%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 27, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Oct 25, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aarti Pharmalabs	64.32B
Innova Captab	56.62B
Orchid Pharma	51.36B
RPG Life Sciences	47.25B
Solara Active Pharma Sciences	27.41B
Indoco Remedies	23.55B
Ind-Swift Laboratories	21.37B
Sakar Healthcare	18.35B

Market Cap Rankings